A laboratory partner with global experience for your CDx development
The improvements precision medicine brings to patient outcomes are both well-known and implemented in clinical practice. Companion Diagnostics (CDx) are assays that are required to be used before a specific therapy can be initiated. They are often co-developed alongside a therapeutic during its clinical development journey. Extensive testing in clinical trials is required, often in multiple sites across the globe. In fact, global solutions are needed due to the increase in clinical development in China and the challenging regulatory conditions on sample import and export. We have supported CDx assays for more than 12 years, and continually enhances its technology, bioinformatics, regulatory, clinical and commercialization aspects. With extensive experience, our organization has the appropriate structure and attributes to help deliver successful CDx programs.